Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression: A Randomized, Open-Label, Non-Inferiority Trial (KetECT).
Ekstrand J, Fattah C, Persson M, Cheng T, Nordanskog P, Åkeson J, Tingström A, Lindström MB, Nordenskjöld A, Movahed Rad P. Ekstrand J, et al. Among authors: movahed rad p. Int J Neuropsychopharmacol. 2022 May 27;25(5):339-349. doi: 10.1093/ijnp/pyab088. Int J Neuropsychopharmacol. 2022. PMID: 35020871 Free PMC article. Clinical Trial.
Effect of electroconvulsive seizures on pattern separation.
Svensson M, Grahm M, Ekstrand J, Movahed-Rad P, Johansson M, Tingström A. Svensson M, et al. Among authors: movahed rad p. Hippocampus. 2015 Nov;25(11):1351-60. doi: 10.1002/hipo.22441. Epub 2015 May 2. Hippocampus. 2015. PMID: 25850383
Ketamine or ECT? What Have We Learned From the KetECT and ELEKT-D Trials?
Ekstrand J, Takamiya A, Nordenskjold A, Kirov G, Sienaert P, Kellner CH, Movahed Rad P. Ekstrand J, et al. Among authors: movahed rad p. Int J Neuropsychopharmacol. 2024 Jan 1;27(1):pyad065. doi: 10.1093/ijnp/pyad065. Int J Neuropsychopharmacol. 2024. PMID: 38114073 Free PMC article.
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
Reif A, Bitter I, Buyze J, Cebulla K, Frey R, Fu DJ, Ito T, Kambarov Y, Llorca PM, Oliveira-Maia AJ, Messer T, Mulhern-Haughey S, Rive B, von Holt C, Young AH, Godinov Y; ESCAPE-TRD Investigators. Reif A, et al. N Engl J Med. 2023 Oct 5;389(14):1298-1309. doi: 10.1056/NEJMoa2304145. N Engl J Med. 2023. PMID: 37792613 Clinical Trial.